Answers - Legal

Fast Relief for Sarbanes Oxley Section 404 Compliance

Section 404 of the Sarbanes-Oxley Act requires management to confirm the effectiveness of their IT and fin

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ancial controls in an "internal control report", which is contained within the annual report (10-K) issued to the public. But what exactly is an internal control report

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

, and why is it important to you?

The Section 404 Internal Control Report

First, the internal control report must affirm management’s responsibility for contro

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ls and procedure, and second, it must contain an assessment of the effectiveness of the internal controls and procedures for financial reporting. Although both of these

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

issues might at first appear difficult to solve, they are actually not as hard as you would think.

Management’s Responsibility for Controls and Procedures

Aff

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

irming management’s responsibility for controls and procedures means more than to simply say management believes in or trusts their system. The affirmation will also ne

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ed to include a program for a code of ethics for senior financial officers. The program must include prompt disclosures of any changes to your ethics program. So how d

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

o you do this?

Business Ethics and Compliance Program

You can easily implement a business ethics program using a step-by-step guide for developing your firm’s

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

business ethics and compliance program. This manual will save you time researching, writing and editing your program. It provides sample policies, surveys, forms and tr

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

aining session outlines that are fully editable using MS Word. And it is also fully endorsed by The National Association of Corporate Directors (NACD) as a tool to main

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

tain a culture of integrity.

Internal Controls

Your internal control report must also contain an assessment of the effectiveness of your internal controls and

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

procedures for financial reporting. In practical terms, control is equivalent to predictability. Everyday management creates forecasts and budgets to predict the futur

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

e. And the further into the future you can accurately predict, then the more control you have.

Achieve More Control Over Your Forecasts and Budgets

A training

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

class for creating well defined processes shows you how to attain more control. Real world exercises and examples explain how to increase management effectiveness, ach

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ieve process control, communicate clear procedures, and verify if your processes are working. So what about procedures?

Procedures Effectiveness

For dealing w

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ith Section 404 of the Sarbanes-Oxley Act, you can look at products like the Management CFO Value Series that includes Accounting, Human Resources, as well as policies,

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

procedures and forms for other departments. Such procedures will save you time researching best practices, creating a standard format, and thinking of clear and concis

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e paragraphs to write.

Easier Section 404 Compliance

Your internal control report is the key to your Sarbanes-Oxley Section 404 compliance. You should also loo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

k at a business ethics and compliance program, attend a training class for creating well-defined processes to learn more about management effectiveness, and use a CFO M

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

anagement Value Series to speed the development of your procedures. You want to achieve fast, easy, and effective relief for your Sarbanes-Oxley Section 404 compliance.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/131336/answers-Sarbanes-Oxley-404-Compliance--How-Nov-15-2004-Deadline-Affects-You.html">Sarbanes Oxley 404 Compliance - How Nov. 15, 2004 Deadline Affects You</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/131336/answers-Sarbanes-Oxley-404-Compliance--How-Nov-15-2004-Deadline-Affects-You.html]Sarbanes Oxley 404 Compliance - How Nov. 15, 2004 Deadline Affects You[/url]

If you are involved in Internet marketing in any way you have heard about business to business sales or B2B, as business to consumer sales or B2C. but have you ever heard of C2C sales or Consumer to Consumer sales websites? Believe me there are a number of consumer to consumer web sites out there that have the ability to transact business. Some people believe that C2C sites include eBay and perhaps they do.

If you've been researching how to make a living online for any amount of time, you've probably seen all the products that have come out recently about making money with niche marketing. You may even understand what niche marketing is but how do you go about making sure you choose a profitable niche?

As the number of online opportunities and competitors grow, more businesses are rethinking the way they measure the effectiveness of their online presence. Many multi-channel marketers rely on Key Performance Indicators (KPIs) to stay on target and help maximize bottom-line performance. It's never too late to maximize your Internet channel's performance. The key is staying tuned in to your KPIs. Eric Dudley, founder and president of WebsiteBiz shares three essential steps for effective use of KPIs.

Tags

Links

Answers - Sarbanes Oxley 404 Compliance - How Nov. 15, 2004 Deadline Affects You

Related Articles: